Editorial
Published on 14 Jan 2025
Editorial: Methods in respiratory pharmacology 2023
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527053
- 116 views
Type at least 3 characters
593 articles
Articles
Review
Accepted on 13 Jan 2025
Silicosis: From pathogenesis to therapeutics
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516200
Case Report
Accepted on 13 Jan 2025
A case report:Interstitial pneumonia following treatment of gastric cancer with Sintilimab in combination with S-1
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1508558
Original Research
Published on 13 Jan 2025
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-ÎşB signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1502165
- 247 views
Editorial
Published on 13 Jan 2025
Editorial: Model organisms in respiratory pharmacology 2023
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1540222
- 148 views
Original Research
Published on 09 Jan 2025
High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1460407
- 189 views
Original Research
Published on 08 Jan 2025
Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1469783
- 178 views
Original Research
Published on 07 Jan 2025
Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504556
- 184 views
Review
Published on 03 Jan 2025
Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474310
- 245 views
Original Research
Published on 03 Jan 2025
A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1400436
- 221 views
Original Research
Published on 03 Jan 2025
α-Bisabolol alleviates diesel exhaust particle-induced lung injury and mitochondrial dysfunction by regulating inflammatory, oxidative stress, and apoptotic biomarkers through the c-Jun N-terminal kinase signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485101
- 135 views
Mini Review
Accepted on 27 Dec 2024
Nanobodies: A Promising Strategy for Asthma Therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510806
Case Report
Accepted on 26 Dec 2024
Re-challenging Pralsetinib following Recovery from Pneumocystis jirovecii Pneumonia in a Lung Cancer Patient: A Case Report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1443609
- 113 views
Original Research
Accepted on 30 Nov 2024
Mitigating Inflammation and Fibrosis: The Therapeutic Potential of Quercetin Liposomes in COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503283
- 441 views
Case Report
Published on 22 Nov 2024
Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16Â months: case report and literature review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1482154
- 448 views
Review
Published on 13 Nov 2024
Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452845
- 834 views